News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 10, 2015, 17:15 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces Expiration Of Bid Deadline In Connection With Agreement To Acquire Assets From Dendreon

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that they have been advised by Dendreon Corporation that no...

Feb 05, 2015, 10:30 ET
Valeant Pharmaceuticals International, Inc.

Valeant Enters Into Amended Agreement To Remain Lead Bidder In Acquisition Of Dendreon And Its Leading Immunotherapy Treatment, PROVENGE® (sipuleucel-T)

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that yesterday it entered into an amended and restated...

Feb 05, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Announce 2014 Fourth Quarter And Full Year Results On February 24, 2015

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...

Jan 29, 2015, 21:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Selected As Lead Bidder To Acquire Dendreon And Its Leading Immunotherapy Treatment, PROVENGE® (sipuleucel-T)

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has entered into a "stalking horse" asset purchase...

Jan 20, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS® Femtosecond Laser Platform

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that its wholly owned subsidiary, Bausch + Lomb, has...

Jan 15, 2015, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces Pricing Of Private Offering Of Senior Notes

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has priced its previously announced offering of...

Jan 15, 2015, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces Redemption of All of the Approximately $500 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that its wholly owned subsidiary, Valeant Pharmaceuticals...

Jan 15, 2015, 09:15 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces Launch of Private Offering of Senior Notes

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has launched an offering of approximately $1.0...

Jan 06, 2015, 10:15 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Present At The J.P. Morgan 2015 Healthcare Conference

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will make a...

Dec 15, 2014, 16:30 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet...

Nov 28, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that its wholly owned subsidiary, Valeant Pharmaceuticals...

Nov 25, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON™ Gel For The Treatment Of Acne Vulgaris

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has received approval from the Food and Drug...

Nov 20, 2014, 11:38 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that its Board of Directors has authorized a new securities...

Nov 18, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Ideal Implant Incorporated today announced the receipt of approval from...

Nov 17, 2014, 09:29 ET
Valeant Pharmaceuticals International, Inc.

Valeant Comments On Allergan Announcement

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today commented on the announcement that Allergan, Inc. (NYSE: AGN) and Actavis plc...

Nov 13, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Completes Renovation Of U.S. Headquarters In New Jersey

Expansion of its U.S. headquarters solidifies commitment to grow jobs and support the local economy Valeant Pharmaceuticals International,...

Nov 07, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Sends Letter To Physician Customers

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today sent a letter to physician customers in order to address...

Nov 04, 2014, 13:27 ET
Valeant Pharmaceuticals International, Inc.

Valeant And Pershing Square May Vote At Special Meeting

 Today, the United States District Court for the Central District of California held that Pershing Square Capital Management, L.P., Valeant...

Oct 27, 2014, 06:55 ET
Valeant Pharmaceuticals International, Inc.

Valeant Delivers Letter To Allergan Board

· Prepared to Improve Offer And Provide Value of at Least $200 a Share · Urges Allergan Board to Take Control of Process...

Oct 20, 2014, 07:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results

  - 2014 Third Quarter Results - Total Revenue $2.1 billion; an increase of 33% over the prior year - Total same store sales...